Vir Biotechnology VIR
NASDAQ VIR
$10.84 +0.10 (+0.88%)
As of: Oct 21, 2026 · 11:41 AM EDT

Vir Biotechnology (VIR) Receivables (2020 - 2022)

Updated

Vir Biotechnology (VIR) posted Receivables of $7 million for Q2 2022, down 99.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Receivables (2020 - 2022) Analysis & Trends

At the end of FY2021, Vir Biotechnology's Receivables came in at $773.08 million.

  • The Q2 2022 figure stands as the lowest quarterly Receivables since Q2 2020.
  • According to Business Quant data, Receivables for the three prior quarters was $1.22 billion (Q1 2022), $773.08 million (Q4 2021) and $93 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 13.82 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.68 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 12.49 Bn
10 Vir Biotechnology 1.82 Bn -138.05 Mn 238.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 7.00 Mn
Mar 31, 2022 1.22 Bn
Dec 31, 2021 773.08 Mn
Sep 30, 2021 93.00 Mn
Mar 31, 2021 225.00 Mn
Jun 30, 2020 3.80 Mn
API Access

Vir Biotechnology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=VIR&period=max&api_key=YOUR_API_KEY